Cargando…

Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

Detalles Bibliográficos
Autores principales: Amir, E, Broom, R, Freedman, O, Ooi, WS, Done, S, Gianfelice, D, Barth, D, Kahn, H, Clemons, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284913/
http://dx.doi.org/10.1186/bcr2310
_version_ 1782351491301900288
author Amir, E
Broom, R
Freedman, O
Ooi, WS
Done, S
Gianfelice, D
Barth, D
Kahn, H
Clemons, M
author_facet Amir, E
Broom, R
Freedman, O
Ooi, WS
Done, S
Gianfelice, D
Barth, D
Kahn, H
Clemons, M
author_sort Amir, E
collection PubMed
description
format Online
Article
Text
id pubmed-4284913
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42849132015-01-15 Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care? Amir, E Broom, R Freedman, O Ooi, WS Done, S Gianfelice, D Barth, D Kahn, H Clemons, M Breast Cancer Res Poster Presentation BioMed Central 2009 2009-06-23 /pmc/articles/PMC4284913/ http://dx.doi.org/10.1186/bcr2310 Text en Copyright © 2009 BioMed Central Ltd.
spellingShingle Poster Presentation
Amir, E
Broom, R
Freedman, O
Ooi, WS
Done, S
Gianfelice, D
Barth, D
Kahn, H
Clemons, M
Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?
title Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?
title_full Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?
title_fullStr Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?
title_full_unstemmed Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?
title_short Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?
title_sort discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284913/
http://dx.doi.org/10.1186/bcr2310
work_keys_str_mv AT amire discordancebetweenhormonereceptorprofileofprimarybreastcancerandmetastaticbonediseaseshouldbonemarrowbiopsybeconsideredastandardofcare
AT broomr discordancebetweenhormonereceptorprofileofprimarybreastcancerandmetastaticbonediseaseshouldbonemarrowbiopsybeconsideredastandardofcare
AT freedmano discordancebetweenhormonereceptorprofileofprimarybreastcancerandmetastaticbonediseaseshouldbonemarrowbiopsybeconsideredastandardofcare
AT ooiws discordancebetweenhormonereceptorprofileofprimarybreastcancerandmetastaticbonediseaseshouldbonemarrowbiopsybeconsideredastandardofcare
AT dones discordancebetweenhormonereceptorprofileofprimarybreastcancerandmetastaticbonediseaseshouldbonemarrowbiopsybeconsideredastandardofcare
AT gianfeliced discordancebetweenhormonereceptorprofileofprimarybreastcancerandmetastaticbonediseaseshouldbonemarrowbiopsybeconsideredastandardofcare
AT barthd discordancebetweenhormonereceptorprofileofprimarybreastcancerandmetastaticbonediseaseshouldbonemarrowbiopsybeconsideredastandardofcare
AT kahnh discordancebetweenhormonereceptorprofileofprimarybreastcancerandmetastaticbonediseaseshouldbonemarrowbiopsybeconsideredastandardofcare
AT clemonsm discordancebetweenhormonereceptorprofileofprimarybreastcancerandmetastaticbonediseaseshouldbonemarrowbiopsybeconsideredastandardofcare